Alpha Cognition Inc.
- Last sale
- Nov 12, 2026 · -1.95%
- Market cap
- $188.34M
- 22.04M shares
- Filings
- 221
Q3 2026
—Q3 2026N/M FY25 yoy
Q3 2026N/M FY25 yoy
Q3 2026derivedN/M FY25 yoy
Q3 2026N/M FY25 yoy
Q3 2026+36.0% FY25 yoy
- $188.34M
- —
- 9.3×
- 3.8×
- -16.37%
- —
Twelve months to Sep 30, 2026 · derived
Price
Nov 12, 2026 · IEX last sale
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Revenue
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $10,220,275 | reported |
Segments
Biological products, except diagnostic substances
Alpha Cognition Inc. is the 62nd largest of the 176 covered companies the SEC files under this code, by revenue. SIC 2836
CompanyRevenueGrowthNet marginMarket cap
RLAYRelay Therapeutics, Inc.$15.4M53.4%1,800.6%$4.0BLCTXLineage Cell Therapeutics, Inc.$14.6M53.2%436.5%$250.5MELUTElutia Inc.$12.3M15.0%434.2%$39.8MCRBUCaribou Biosciences, Inc.$11.2M11.7%1,327.4%$40.8MTCRXTScan Therapeutics, Inc.$10.3M266.7%1,256.8%$11.1M
ACOGAlpha Cognition Inc. (this company)$10.2M—202.2%$188.3M
TSHATaysha Gene Therapies, Inc.$9.8M17.3%1,115.3%$1.3BCRISCuris Inc$9.4M13.4%80.3%$1.2MFATEFate Therapeutics Inc$6.6M51.2%2,051.1%$161.7MPeers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in revenue first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.
Alpha Cognition Inc. · CIK 1655923 · Engraved from SEC EDGAR